Article | April 16, 2024

Tips For Viral Vector Production

Source: Cytiva

This article delves into the challenges of viral vector manufacturing, a burgeoning sector driven by the demand for cell and gene therapies as well as vaccines. Emphasizing scalability and GMP compatibility, it underscores the need for well-characterized cell lines and high-quality materials. Regulatory requirements, analytical hurdles, and upstream processing are highlighted.

Downstream processing, crucial for maintaining virus infectivity and stability, is discussed. Optimization strategies to enhance recovery and streamline processes are recommended, including filtration and chromatography while minimizing shear forces.

Effective clarification methods, such as depth filtration, are suggested for efficient recovery, along with addressing challenges in removing host cell DNA (hcDNA) through DNase treatment.

To boost capacity, the article advises the use of chromatography membranes or modern resins, considering the impact of virus characteristics on chromatography steps. Challenges in elution conditions for virus particles are acknowledged and require optimization.

Learn more about how meticulous purification optimization can maximize recovery and impurity removal by leveraging scalable downstream technologies to meet regulatory and process economy requirements by accessing the full article below.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online